Institute for Medical Education and Research, Madelyn Trupkin Herzfeld, IMER, imer, imier, Miami, Florida, Nursing CE's, Nursing contact hours, nursing education, continuing education, medical research and education, Oncology, Postgraduate credit, oncology nurses, nurses, symposia, symposium, online educational credit, Breast Cancer, Cancer, cancer, breast cancer, colorectal cancer, Colorectal Cancer, Targeting EGFR, EGFR Inhibitors, egfr inhibitors, head and neck cancer, Anti-VEGF, VEGF Inhibitors, vegf inhibitors, lung cancer, head cancer, CINV, cinv, Chemotherapy Induced Nausea & Vomiting, chemotherapy, nausea, vomiting, mucositis, cancer pain, chronic pain  
IMER Oncology Nurse Regional Tour
   
  CE REGIONAL MEETINGS FOR ONCOLOGY NURSES

IMER Regional Meeting

Call-to-Action Workshop: Oncology Nurse Management of Hypersensitivity Reactions

Sponsored by:

IMER

Target Audience

This activity has been designed to meet the needs of patient care oncology nurses.

Purpose

To educate nurses on effective treatment strategies for the management of hypersensitivity reactions (HSRs).

Program Overview

Numerous cancer therapies are associated with HSRs. These infusion-related reactions can range in severity from mild flushing and itching, to anaphylaxis, and in rare cases, death. The accurate identification of the signs and symptoms of HSRs can directly affect treatment decisions. If patients at high risk for experiencing a second reaction can be safely rechallenged, discontinuation of an effective agent may be avoided. It is imperative that oncology nurses are aware of the potential for HSRs when administering therapeutic agents and have protocols in place to prevent and manage these reactions in order to minimize their impact on future treatment. This unique educational workshop will begin with an overview of systemic cancer therapies commonly associated with HSRs, to be followed by a brief teleconference presentation reviewing HSR pathophysiology in 3-D video animation. The remainder of the program will focus on HSR prophylaxis and management. Effective prophylaxis and management protocols will be presented. The program will conclude with a leadership workshop on the empowerment of oncology nurses in the initiation of task forces to implement such protocols to optimize patient care and outcomes at their institutions. Nurse participants will be provided a comprehensive reference guide including presentation slides with annotations to clinical assessment/management tools, and oncology certification examination blueprints, glossaries of terms, and complete reference lists.

Learning Objectives

Upon completion of this program, participants should be better able to:

  • Identify which systemic cancer therapies often cause HSRs
  • Describe the pathophysiology of HSRs caused by systemic cancer therapies
  • Describe the clinical signs and symptoms of mild, moderate, and severe HSRs
  • Identify the variations in timing of HSRs across systemic cancer treatments
  • Describe the appropriate prophylaxis and management of HSRs caused by various systemic cancer treatments
  • Identify the optimal circumstances and methods for rechallenging patients who have experienced HSRs to systemic cancer therapy

Chairperson

Pamela H. Viale, RN, MS, CS, ANP AOCNP®
University of California, San Francisco

 

This activity is supported by independent educational grants from Bristol-Myers Squibb Company and sanofi-aventis U.S.
 

Additional CE Meetings on This Topic:

Click on the column headers to sort and on a city for more details.
{date} {city} {speaker}

{icon}
{location}

 

More meetings to be added in the near future. Check for updates.

 

Disclosure of Conflicts of Interest

The Institute for Medical Education & Research (IMER) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by IMER for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accreditation Statements

This educational activity for 1.0 contact hour will be provided by IMER. IMER is an approved provider of continuing education by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

IMER is approved by the California Board of Registered Nursing, Provider Number 14763 for 1.2 contact hours.

Application pending approval with the American Academy of Nurse Practitioners (including pharmacology hours).